Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
Abstract
During the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more attention should be paid to the balance of risks and benefits associated with proton pump inhibitors for the following reasons. One of the main functions of gastric juice is to inactivate swallowed microorganisms, thereby inhibiting infectious agents from reaching the intestine. Studies have documented that proton pump inhibitors are a risk factor...
Paper Details
Title
Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
Published Date
Aug 10, 2020
Journal
Volume
40
Issue
10
Pages
897 - 899
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History